Covered recipient · General Payments record
CHINWENDU OPARA
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2019–2024
$226.34
- Reported across 12 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $164.23 | 9 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Exact Sciences Corporation | $37.75 | 2 |
| Acerta Pharma LLC | $35.61 | 2 |
| Lilly USA, LLC | $27.99 | 2 |
| Astellas Pharma US Inc | $23.64 | 1 |
| PFIZER INC. | $22.71 | 1 |
| Novo Nordisk AS | $16.53 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (9)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Astellas Pharma US Inc | $23.64 | 07/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139284286 | CMS |
| AstraZeneca Pharmaceuticals LP | $17.42 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104489874 | CMS |
| AstraZeneca Pharmaceuticals LP | $18.19 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105341966 | CMS |
| Exact Sciences Corporation | $19.52 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114417009 | CMS |
| Exact Sciences Corporation | $18.23 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114417014 | CMS |
| Lilly USA, LLC | $14.50 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136096149 | CMS |
| Lilly USA, LLC | $13.49 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136117651 | CMS |
| Novo Nordisk Inc | $16.53 | 08/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096891511 | CMS |
| PFIZER INC. | $22.71 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131671788 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2019, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2019 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.